| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/12/2007 | CA2624170A1 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2624030A1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 04/12/2007 | CA2623826A1 Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection |
| 04/12/2007 | CA2623154A1 Novel fused pyrrole derivative |
| 04/12/2007 | CA2623094A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | CA2623011A1 New formulation |
| 04/11/2007 | EP1772517A2 DSP-3 dual specificity phosphatase |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1772454A1 Nitrogenous fused bicyclic compound |
| 04/11/2007 | EP1772149A1 Drug for prevention or treatment of diabetes |
| 04/11/2007 | EP1772148A1 Lipase inhibitors |
| 04/11/2007 | EP1772143A1 Peroxisome proliferator-activated receptor (ppar) activator and drugs, supplements, functional foods and food additives using the same |
| 04/11/2007 | EP1772066A1 Health food, process for producing the same and dried matter or extract |
| 04/11/2007 | EP1771444A1 Salt of oxalic acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)-amino)ethoxy]benzyl]thiazolidin-2,4-dione and a method of its preparation and its use |
| 04/11/2007 | EP1771428A1 Guanidine derivatives and therapeutic uses thereof |
| 04/11/2007 | EP1771426A1 Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1b (ptp1b) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes |
| 04/11/2007 | EP1771425A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 04/11/2007 | EP1771424A1 Novel 2,4-diaminothiazol-5-one derivatives |
| 04/11/2007 | EP1771194A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 04/11/2007 | EP1771193A1 Gus3 neuropeptides for regulating hypothalamic function |
| 04/11/2007 | EP1771191A2 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 04/11/2007 | EP1771188A2 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia |
| 04/11/2007 | EP1771178A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 04/11/2007 | EP1771171A1 Use of alk 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals |
| 04/11/2007 | EP1771166A2 Rxr antagonists in the treatment of inflammatory diseases |
| 04/11/2007 | EP1771162A2 Capsaicin inhibitors for treating obesity and related disorders |
| 04/11/2007 | EP1771153A1 Composition for delivery of an active agent |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1480972B1 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1123094B1 Therapeutic compositions (ii) |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | CN1946717A Benzimidazole derivative and its use |
| 04/11/2007 | CN1946712A Pyrrolidine derivative |
| 04/11/2007 | CN1946702A Tri(cyclo) substituted amide compounds |
| 04/11/2007 | CN1946698A Pyrazole phenyl derivatives as ppar activators |
| 04/11/2007 | CN1946697A Substituted pyrazoline compounds for reducing triglycerides in blood |
| 04/11/2007 | CN1946690A Cyclobutenedione groups-containing compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946688A Atorvastatin calcium in amorphous form |
| 04/11/2007 | CN1946415A Formulation for treating obesity and associated metabolic syndrome |
| 04/11/2007 | CN1946399A Method of treating schizophrenia and/or glucoregulatory abnormalities |
| 04/11/2007 | CN1946398A Thiadiazolidinones as gsk-3 inhibitors |
| 04/11/2007 | CN1944452A 2-phenoxy chromone heteroside compounds and its preparing method and use |
| 04/11/2007 | CN1944448A Puerarin derivative and its medicinal use |
| 04/11/2007 | CN1944383A Alpha-alkoxy propionic acid compounds and their preparing method and medicine use |
| 04/11/2007 | CN1943786A Ester compound and its medicinal application |
| 04/11/2007 | CN1943776A The onion blood pressure decreasing capsule, oral liquid, tablet and their preparation method |
| 04/11/2007 | CN1943762A A Medicine for treatment of fatty liver and its preparation method |
| 04/11/2007 | CN1943735A The preparation method of a kind of radix ophiopogonis extract and its use |
| 04/11/2007 | CN1943733A The preparation method of glutinous millet for reducing blood fat protein |
| 04/11/2007 | CN1943721A A Chinese traditional externally use medicinal composition for treatment of diabetic feet |
| 04/11/2007 | CN1943719A A Chinese traditional medicinal composition for treating diabetes and its preparation method |
| 04/11/2007 | CN1943713A A Chinese traditional medicinal composition for treating diabetes and its preparation method |
| 04/11/2007 | CN1943705A The application of rhizoma anemarrhenae extract in preparing medicine to improve the counteraction of insulin |
| 04/11/2007 | CN1943702A A Chinese traditional medicinal composition for treatment of hyperlipemia and its preparation method |
| 04/11/2007 | CN1943685A A giantarum fat-reducing granule containing oligo polyflavanol and preparation method and use |
| 04/11/2007 | CN1943684A A composition used for regulating blood-fat and its preparation method |
| 04/11/2007 | CN1943679A A spiny grape seed extract preparation and its preparation method |
| 04/11/2007 | CN1943613A Granular agent with brain strengthening function |
| 04/11/2007 | CN1943602A Bee pollen bee glue composition and its preparing method |
| 04/11/2007 | CN1943594A Oral disintegrating tablet of lysine calcium mono hydrogen phosphate |
| 04/11/2007 | CN1943563A Vitamin dripping pill and its preparing method |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309813C Oil or fat composition |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309718C Novel modifications of aminobutantriol salt of R-thioctic acid and method for producing the same |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309391C Compound phenformin |
| 04/11/2007 | CN1309384C 4-piperazinyl benzenesulfonyl indoles with 5-HT6 receptor affinity |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/11/2007 | CN1309377C Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels |
| 04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
| 04/10/2007 | US7202394 Animal with the mass expression of human gene and test method by using the animal |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202350 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives, are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202267 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
| 04/10/2007 | US7202210 Premature peptide for use in treatment of nervous system, muscular, heart, diabetic and bone disorders |
| 04/10/2007 | US7202080 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | CA2473370C Method for decreasing bioprosthetic implant failure |
| 04/10/2007 | CA2470066C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2314848C Process for preparing beadlets containing fat-soluble substances |
| 04/10/2007 | CA2307068C Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2292706C Method for administering viable microorganism composition for poultry |
| 04/10/2007 | CA2287476C Conjugated linolenic acid-based synthetic triglycerides |
| 04/10/2007 | CA2270469C Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 04/10/2007 | CA2222068C Chimeric fatty body-pro-grf analogs with increased biological potency |
| 04/10/2007 | CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof |
| 04/10/2007 | CA2153937C Tricyclic pyrazole derivatives |
| 04/07/2007 | CA2562767A1 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 04/05/2007 | WO2007038452A1 Process for synthesizing 1,2,4-triazoles |